Kareo and digiChart Collaborate to Provide Specialized, Integrated Solutions for OB/GYN Practices

IRVINE, Calif.--Kareo, the leading provider of cloud-based medical office software for small medical practices, today announced it has entered into a partnership with digiChart, a provider of specialty-specific EHR technology for OB/GYN practices. Through this collaboration, Kareo’s cloud-based practice management and billing solutions will seamlessly integrate with digiChart’s specialty EHR to provide the OB/GYN market with a robust, specialized solution for managing the clinical and business aspects of their practice.

Integrating digiChart’s specialty-specific functionality—including formatted treatment plans, OB flowsheets, and an electronic antepartum record—with Kareo’s purpose-built practice management and billing solutions, will provide digiChart clients with the ability to optimize operations, achieve improved financial performance and enhance patient engagement.“OB/GYN providers often require specialized workflow and functionality, making it imperative that providers are enabled with innovative solutions suited to their specialty,” says Dan Rodrigues, founder and CEO of Kareo. “We are pleased to be partnering with digiChart as we work to help independent specialty practices spend more quality time with their patients.”

“Kareo has proven itself as the true market leader in the small practice space,” says Rodney Hamilton, M.D., CEOof digiChart. “We believe Kareo’s unique mission and innovative technology combined with our knowledge of the clinical OB/GYN space results in the most targeted and comprehensive suite of solutions in the market.”

digiChart’s EHR, which serves more than 1,000 OB/GYN clinicians nationwide, is the latest specialty EHR addition to Kareo Marketplace, a curated listing of cloud-based applications and value-added services to support small practices. All of the solutions offered in Kareo Marketplace can be seamlessly integrated and build upon Kareo’s medical office software platform. Kareo Marketplace currently provides a curated selection of EHR partners that cover the unique requirements of more than 15 medical specialties.

About Kareo

Kareo is the only cloud-based medical office software and services platform purpose-built for small practices. At Kareo, we believe that, with the right tools and support, small practices can do big things. We offer an integrated solution of products and services designed to help physicians get paid faster, run their business smarter, and provide better care. Our practice management softwarebilling services, fully certified EHR help more than 25,000 medical providers more efficiently manage the business and clinical sides of their practice. Kareo has received extensive industry recognition, including the Deloitte Technology Fast 500, Inc. 500/5000, Forbes Top 100 Most Promising Companies, and Black Book #1 Integrated EHR, Practice Management and Billing Vendor. Headquartered in Irvine, California, the Kareo mission is to help providers spend their time focused on patients, not paperwork. For more information, visit www.kareo.com.

About digiChart

digiChart delivers a comprehensive, specialty electronic health record (EHR) system, as well as practice management and revenue cycle solutions through strategic partnerships to help its practitioners improve quality, increase revenue and enhance patient relationships. The company’s flagship offering is tailored to the specific workflow needs of OB/GYN providers and is the EHR of choice for hundreds of practices nationwide. A privately held company, digiChart is based in Brentwood, Tennessee with investors including MedCare Investment Funds and Vanderbilt University Medical Center. For more information, call (877) 634-2727 or visit www.digichart.com. Follow digiChart on FaceBook, Twitter and LinkedIn.

 

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.